Accessibility Menu
Trulieve Cannabis logo

Trulieve Cannabis(NYSE) TRLV

Market Cap$1.85BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2018)-22%
5 Year-68%
1 Year+7%
1 Month+6%
$9.68
+6.26%
+0.57Today
After hours$9.65-$0.03 (-0.31%)
Trulieve Cannabis last closing stock price
MetricPriceDate
Last closeUSD 9.602026-08-13
Trulieve Cannabis stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+6.67%USD 9.002026-08-06
1 month+5.96%USD 9.062026-07-14
3 month+32.23%USD 7.262026-05-15
Year to date+10.47%USD 8.692025-12-31
1 year+6.67%USD 9.002025-08-13
3 year+143.65%USD 3.942023-08-14
5 year-67.96%USD 29.972021-08-13
Since inception-21.97%USD 11.682018-09-28

Trulieve Cannabis Financials at a Glance

Market Cap

$1.85BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.14B

Net Income (TTM)

-$473.39M

EPS (TTM)

-$2.46

P/E Ratio

-3.90

Dividend

$0.00

Beta (Volatility)

0.71 (Low)

Price

$9.68

Volume

26

Open

$9.15

Previous Close

$9.60

Daily Range

$9.02 - $9.90

52-Week Range

$4.62 - $13.28

Estimated Earnings Date

Aug 6, 2026

About Trulieve Cannabis

Trulieve Cannabis Corp. is a leading player in the cannabis industry, focusing on the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. The company operates its own facilities and distributes products through branded stores and home delivery services.

Products and Services
  • Wide range of medical and adult-use cannabis products
  • In-house cultivation and production for quality control
  • Direct home delivery services for patient convenience
Growth Outlook
  • Revenue of $286.8 million in Q1 2026, showing strong demand
  • Operating income of $35.4 million indicates operational efficiency
  • Current ratio of 5.26 suggests strong liquidity position
Financial Highlights
  • Net income of $2.4 million in Q1 2026, a positive shift
  • Gross profit margin of 59.3% reflects effective cost management
  • Cash flow from operations of $55.7 million supports growth initiatives
Trulieve Cannabis Corp. has established itself as a significant entity in the cannabis sector, with a robust operational framework and a diverse product portfolio. The company's recent financial performance indicates a positive trajectory, with increasing revenues and a solid gross profit margin. The liquidity position is strong, allowing for potential investments in growth opportunities. As the cannabis market continues to expand, Trulieve's strategic initiatives and operational efficiencies may position it favorably for future success.
AI Generated • Jul 20, 2026

Industry

Pharmaceuticals

Employees

5,000

CEO

Kimberly A. Rivers

Headquarters

Tallahassee, FL 32312, US

TRLV Financials

Key Financial Metrics (TTM)

Gross Margin

54.60%

Operating Margin

13.57%

Net Income Margin

-6.99%

Return on Equity

-6.88%

Return on Capital

8.60%

Return on Assets

-2.94%

Earnings Yield

-25.64%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.85BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

192.31M

Volume

26

Avg. Volume

1.13M

Financials (TTM)

Gross Profit

$677.39M

Operating Income

-$274.26M

EBITDA

-$138.29M

Operating Cash Flow

$244.80M

Capital Expenditure

-$57.98M

Free Cash Flow

$186.82M

Cash & ST Invst.

$325.42M

Total Debt

$260.61M

Trulieve Cannabis Performance Analysis

Trulieve Cannabis annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 1,218,229,00029.9%
20232023-12-31USD 1,129,193,000-7.3%
20242024-12-31USD 1,186,490,0005.1%
20252025-12-31USD 1,181,180,000-0.4%
Trulieve Cannabis sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-4.6%
Q42025-12-311.7%
Q12026-03-31-2.2%
Q22026-06-30-5.5%
Trulieve Cannabis annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -1.31N/A
20232023-12-31USD -2.79113.0%
20242024-12-31USD -0.82-70.7%
20252025-12-31USD -0.61-25.5%
Trulieve Cannabis sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-100.0%
Q42025-12-31-57.1%
Q12026-03-31104.5%
Q22026-06-30-21100.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$270.95M

-10.3%

Gross Profit

$162.29M

-11.3%

Gross Margin

59.90%

N/A

Market Cap

$1.85BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$369.23K

N/A

Employees

5,000

N/A

Net Income

-$406.06M

-2846.7%

EBITDA

-$370.64M

-476.5%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$325.42M

-17.1%

Total Debt

$260.61M

-68.4%

Accounts Receivable

$4.01M

-81.0%

Inventory

$186.87M

-22.6%

Long Term Debt

$235.00M

-70.4%

Short Term Debt

$25.62M

-10.8%

Return on Assets

-2.94%

N/A

Return on Invested Capital

5.97%

N/A

Free Cash Flow

$32.10M

-53.8%

Operating Cash Flow

$53.10M

-38.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,794.24+0.01%
^DJIDJI
$53,765.45-0.00%
^IXICNASDAQ
$26,793.14+0.01%
BTCBitcoin
$63,131.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$145.36+0.02%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$40.12-0.02%
ONDSOndas
$8.91-0.09%
MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x ETF
$31.00+0.09%

Questions About TRLV

What is the current price of Trulieve Cannabis?

Trulieve Cannabis is trading at $9.60 per share.

What is the 52-week range for Trulieve Cannabis?

Over the past 52 weeks, Trulieve Cannabis has traded between $4.62 and $13.28.

How much debt does Trulieve Cannabis have?

As of the most recent reporting period, Trulieve Cannabis reported total debt of $577.26M.

How much cash does Trulieve Cannabis have on hand?

Trulieve Cannabis reported $325.42M in cash and cash equivalents in its most recent financial results.

What is Trulieve Cannabis’s dividend yield?

Trulieve Cannabis does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.